Lumexa Imaging Holdings, Inc. (LMRI)
NASDAQ: LMRI · Real-Time Price · USD
14.06
+0.05 (0.36%)
Nov 19, 2026, 4:00 PM EST - Market closed
Lumexa Imaging Holdings Stock Forecast
Stock Price Forecast
According to 10 analysts polled by S&P Global, Lumexa Imaging Holdings stock has a consensus rating of "Strong Buy" and an average price target of $18.78. The average 1-year stock price forecast is 33.57% higher than the current stock price, while the lowest is $16 (+13.80%) and the highest is $23 (+63.58%).
Price Target: $18.78 (+33.57%)
Analyst Consensus: Strong Buy
Price Target
ChartAnalyst Ratings
The average analyst rating for Lumexa Imaging Holdings stock is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Jun '26 | Jul '26 | Aug '26 | Sep '26 | Oct '26 | Nov '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 6 | 6 | 6 | 7 | 8 | 8 |
| Buy | 2 | 2 | 2 | 2 | 2 | 2 |
| Hold | 0 | 0 | 0 | 0 | 0 | 0 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 8 | 8 | 8 | 9 | 10 | 10 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Wells Fargo | Wells Fargo | Buy Maintains $19 → $21 | Buy | Maintains | $19 → $21 | +49.36% | Nov 18, 2026 |
| Barclays | Barclays | Buy Maintains $13 → $17 | Buy | Maintains | $13 → $17 | +20.91% | Nov 17, 2026 |
Unknown Analyst Leerink Partners No rating | Leerink Partners | Buy Maintains $17 → $19 | Buy | Maintains | $17 → $19 | +35.14% | Nov 13, 2026 |
| Raymond James | Raymond James | Buy Reiterates $19 | Buy | Reiterates | $19 | +35.14% | Nov 11, 2026 |
| Truist Financial | Truist Financial | Buy Initiates $18 | Buy | Initiates | $18 | +28.02% | Oct 5, 2026 |
Financial Forecast
Revenue This Year
1.07B
from 1.02B
Increased by 4.45%
Revenue Next Year
1.13B
from 1.07B
Increased by 5.55%
EPS This Year
0.86
from 0.18
Increased by 377.27%
EPS Next Year
0.94
from 0.86
Increased by 9.57%
EPS and Forward PE are based on non-GAAP adjusted numbers.